本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Solid Biosciences

7.00
+0.32004.79%
盘后6.98-0.0201-0.29%19:55 EDT
成交量:151.58万
成交额:1,026.34万
市值:5.43亿
市盈率:-2.40
高:7.00
开:6.70
低:6.47
收:6.68
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
更多
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
2024/11/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/01

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/02

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/15

SEC问询函

Form CORRESP - Correspondence
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

SEC问询函

Form CORRESP - Correspondence

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”